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Abstract 
Background: Unique properties exhibited by nanoparticles makes them great candidates for applications in physics, 
chemistry, biology, material science and medicine. The biological applications of water‑soluble gold nanoparticles 
range from contrast agents, delivery vehicles to therapeutics. Notch signaling is a complex network that orchestrates 
cell fate decisions, which involves proliferation, migration, differentiation and cell death in organisms ranging from 
insects to humans. Studies have showed that a correct orientation of the Jag‑1 signalling protein on the substrates 
proves to be of great importance when promoting Jagged‑1 Notch interactions, also the availability of the ligands, 
super cedes the importance of their concentration.
Results: The aim of the present study was to synthetize a Jag‑1 functionalized nanocarrier, which would promote an 
efficient interaction between the Jag‑1 peptide and the Notch receptor. To this end, two routes for gold nanoparticle‑
peptide assembly were investigated, and the synthetized bio‑nanostructures were characterized and compared by 
means of UV–Vis, FT‑IR, DLS and AFM techniques.
Conclusions: We have obtained a stable, monodisperse, hetero‑functionalized GNP‑PEG‑JAG‑1 bio‑nanostructure for 
Notch pathway activation applications.
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Background
Notch signaling is a complex network that orchestrates 
cell fate decisions, which involves proliferation, migra-
tion, differentiation and cell death in organisms ranging 
from insects to humans [1, 2]. Ligands such as Jagged-1,-2 
and Delta-1,-3 and -4 have been found to activate the 
mammalian Notch transmembrane receptor (Notch-1 to 
-4) [1, 3, 4]. Kertesz et al. showed that Jagged-Fc adsorbed 
on the surface of particles enhances the proliferation of 
ex vivo hematopoietic stem cells [5]. Another study con-
ducted by Nickollof et al. demonstrated that a 17 amino 
acid peptide dubbed Jag-1 mimics the function of full-
length Jagged-1 protein and can be used as an agonist 
in order to activate the Notch pathway [2]. Studies have 
showed that a correct orientation of the Jag-1 signalling 
protein on the substrates proves to be of great impor-
tance when promoting Jagged-1 Notch interactions, also 
the availability of the ligands, super cedes the importance 
of their concentration [1, 4].
Unique properties exhibited by nanoparticles makes 
them great candidates for applications in physics, chem-
istry, biology, material science and medicine [6]. In recent 
years, gold nanoparticles have gained great attention in 
the eyes of the medical community, firstly, due to the fact 
that the gold core is essentially inert and non-toxic [7]. 
The biological applications of water-soluble gold nano-
particles range from contrast agents, delivery vehicles to 
therapeutics [8]. Another key feature for these gold nano-
structures is the ease of synthesis of mono-disperse nan-
oparticles with sizes ranging from 1 to 150 nm [7]. The 
most common technique used to prepare aqueous-stable 
gold nanoparticles for biological studies is the citrate 
reduction method, first featured by Turkevich et  al. [9]. 
In this case Au3+ ions are reduced to metallic gold and 
stabilized by a citrate ligand layer through electrostatic 
interactions [10]. Investigations of citrate capped gold 
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nanoparticles showed that they have a negatively charged 
surface and preferentially bind to thiol, amine and cya-
nide functional groups [11]. In order to further stabilize 
and modulate their physico-chemical properties, gold 
nanoparticles have been functionalized with a wide range 
of simple and complex molecules by means of their reac-
tive functional groups [12]. For example, peptides [13], 
proteins [14], DNA [15], polymers [16], and dendrimers 
[17] were conjugated to the gold nanoparticles surface by 
means of non-covalent electrostatic interaction, hydro-
phobic interaction and covalent binding [12, 14].
Some molecular methods for incorporating peptides 
and oligonucleotides present themselves as relatively 
inefficient, limit the peptide sequence diversity because 
of chemistry incompatibility and can generate undesired 
products. In order to functionalize nanoparticles with 
biomolecules two types of functionalization methods are 
employed: homo- and heterofunctionalization. The first 
one refers to a straight forward approach, where only 1 
biomolecule functionality is incorporated (e.g. peptide, 
antibody, DNA), while the latter one refers to the incor-
poration of 2 or more biomolecule functionalities (e.g. 
protein-stabilized DNA-peptide conjugate) [15, 18–21].
The aim of the present study was to synthetize a Jag-1 
functionalized nanocarrier, which would promote an 
efficient interaction between the Jag-1 peptide and the 
Notch receptor. To this end, two routes for gold nan-
oparticle-peptide assembly were investigated, and the 
synthetized bio-nanostructures were characterized and 
compared by means of UV–Vis, FT-IR, DLS and AFM 
techniques.
Methods
Choloroauric acid (HAuCl4, ≥99.9%), tri-sodium citrate 
(≥99%), disodium phosphate (Na2HPO4, ≥99%), dime-
thyl sulfoxide (DMSO ≥99.7%) and poly(ethylene gly-
col) dithiol (average Mn  =  3,400) were purchased from 
Sigma-Aldrich (Darmstadt, Germany). JAG-1 peptide 
active fragment was purchased from StemRD (CA, USA). 
Reagents were used as received without further purifica-
tion. All glassware used in the experiments was cleaned 
with aqua regia (HCl: HNO3, 3:1) prior to use.
JAG-1 peptide cell penetration prediction was per-
formed with the aid of the web-based CellPPD server 
[22], the SVM+ motif with a threshold of 0.1 and an 
E-value cut-off of 10. The 3D structure of the peptide was 
predicted by the PEPstr [23] web-based server and the 
structure validated with the VADAR server [24, 25].
The MC3T3-E1 osteoblast cell line was purchased and 
maintained using standard cell culture protocols [Euro-
pean Collection of Cell Cultures (ECACC)]. When reach-
ing the growth log-phase, test sample cells were exposed 
to GNP-PEG-JAG-1 by medium removal and addition 
GNP-PEG-JAG-1 solution in appropriate concentrations 
(34.5, 17.3, 8.6, 4.3, 2.1 μg mL−1, respectively). A volume 
of 400 μL/well for 4 chamber slides, or 100 μL/well for 96 
well plates was used. Next, 1 h incubation (5% CO2, 37°C) 
was allowed for exposure. Control sample was exposed to 
appropriate culture medium [MEM alpha +  2 mM glu-
tamine + 10% fetal bovine serum (FBS)].
The synthesis of gold nanoparticles was done in accord-
ing to a modified Turchevich method. Briefly, 29  mg of 
HAuCl4 were dissolved in 50 mL ultrapure water under 
vigorous agitation. To this, a 5  mL solution of sodium 
citrate 50  mM was quickly added and the solution was 
brought to boiling. The reaction was allowed to continue 
for 1 h under reflux. Afterwards, the obtained ruby-red 
solution was cooled to room temperature and aliquots 
were pulled for characterization purposes.
For coupling of the JAG-1 peptide on the gold nanopar-
ticle surface two routes were undertaken.
Route I: The pH of a 5  mL solution of citrate capped 
GNPs (11.5  nM) was adjusted to ~7 with the aid of a 
0.1  M Na2HPO4 solution. Next, 500  μL of the JAG-1 
solution 5  μM were added under continuous stirring. 
The reaction between the GNPs and the JAG-1 peptide 
was allowed to continue for 1  h under stirring at room 
temperature. In order to separate the functionalized 
GNP-JAG-1 nanocomposite from the uncoupled JAG-1 
peptide the sample was subjected to a 16,000 RPM cen-
trifugation step for 30  min. The supernatant was dis-
carded and the obtained pellet was re-dispersed in 
ultrapure water by means of ultrasonication.
Route II: The pH of a 10  mL 5  nM solution of cit-
rate capped GNPs was adjusted to ~7 with the aid of a 
0.1  M Na2HPO4 solution. Next 1  mL of PEG dithiol 
(Mn =  3,400) 100 μM was added and the reaction was 
allowed to continue for 30 min under continuous stirring. 
Afterwards, 1 mL of 5 μM JAG-1 solution and 1 mL of 
DMSO 100 μM were added to the sample. The reaction 
was allowed to continue 120  min at room temperature, 
under continuous stirring. The conjugate was purified by 
centrifugation at 13,200 RPM for 20 min, and the result-
ing pellet was re-dispersed in ultrapure water by means 
of ultrasonication.
UV–Vis spectroscopy sample characterization was 
done on a Shimadzu UV-1800® instrument. Spectral data 
were collected in the 800–200 nm range, with a 0.5 nm 
resolution at room temperature. A 1 cm lightpath quartz 
cuvette was used and samples were diluted (1:10 v/v) 
prior to the measurements. All recorded spectras were 
normalized using the OriginLab software® 7.0.
Dynamic light scattering measurements were con-
ducted on a Zetasizer—Nano S90 Malvern Instrument 
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(Westborough, UK). A 90° scattering angle, 25  ±  0.1°C 
and a refractive index of 1.4 were considered for all sam-
ples. Measurements were carried out in triplicate.
Universal attenuated total reflectance Fourier-trans-
form infrared spectroscopy (UATR-FT-IR) spectral char-
acterization was done with the aid of a Perkin-Elmer 
Spectrum Two® instrument equipped with an attenuated 
total reflectance stage (ATR), with over 128 scans per 
sample and a resolution of 1 cm−1. Baseline corrections 
and spectra processing were done with the Spectrum 10 
software.
Atomic force microscopy images were collected with a 
Workshop TT-AFM® instrument (AFMWorkshop, CA, 
USA), operating in vibrating mode with ACTA-SS can-
tilevers (AppNano, CA, USA). Samples were deposited 
on a mica surface by means of a spin coater (KLM® SCC). 
The collected images were processed with the Gwyddion® 
software ver. 2.36.
High contrast dark-field imaging (100×) of GNP and 
GNP-PEG-JAG-1 samples was done on an Olympus 
BX-43 microscope with a CytoViva® modification. For 
each sample, an amount of 15  μL was deposited on a 
glass slide and sealed with a cover slip.
Cell growth and viability was assessed by measur-
ing the ability to cleave 3-[4, 5-dimethylthiazol-2-yl]-2, 
5-diphenyl tetrazolium bromide (MTT). For performing 
the assay (Molecular Probes), cells were seeded into a 96 
well plate. Briefly, following exposure, cells were incu-
bated with the MTT solution (4 h, 37°C). Next, SDS-HCl 
addition was performed, followed by incubation (4  h, 
37°C). Absorbance was read spectrophotometrically at 
570 nm using the fluorescence modulus of a Perkin Elmer 
Viktor multilabel multitask plate reader. Experiments 
were performed in triplicate. Results were expressed as 
percentage calculated from non-exposed group’s absorb-
ance. SPSS 17.0 (Chicago, Il) statistical package was used 
for data analysis. Kruskall Wallis and Mann–Whitney U 
Test were used to assess overall among-group and two-
group differences respectively. A threshold of p  <  0.05 
was considered significant. Data was expressed as mean 
(std. error).
Results
Gold nanoparticles were synthetized by employing a 
modified Turchevich method. This approach yields 
mono-disperse citrate-capped metallic gold nanostruc-
tures. The obtained GNPs showed themselves as stable 
in aqueous media over several weeks and were charac-
terized by means of UV–Vis, ATR-FT-IR, and DLS tech-
niques. The surface plasmon resonance band (SPR) for 
the GNP solution, as determined by UV–Vis spectros-
copy, was located at 522  nm, value in agreement with 
other literature data [24, 26–28]. The concentration of 
the GNP solution was calculated to be 11.5 nM based on 
the extinction coefficient at 522  nm [29, 30]. Dynamic 
light scattering (DLS) measurements conducted on the 
GNPs revealed a hydrodynamic diameter of 16 ± 2 nm.
The JAGGED-1 peptide has 17 aminoacid residues (one 
letter code: CDDYYYGFGCNKFCRPR) of which three 
are cysteine residues. Data generated by CellPPD, PEP-
str and VADAR peptide prediction servers showed that 
JAG-1 is a non-cell penetrating peptide that has a molec-
ular weight of 2,107.37 Da, a pI =  8.22 and a predicted 
3D coil type structure.
In order to functionalize the obtained GNPs with the 
JAG-1 peptide, two routes were taken into consideration, 
a homo- and a heterofunctionalization approach, they 
are illustrated in Figure  1. Route I aimed to couple the 
JAG-1 peptide directly on the GNPs surface through the 
thiol functional groups from the cysteine residues pre-
sent in the mentioned peptide. Another functionalization 
route (route II) investigated was the coupling of JAG-1 
to a dithiol PEG spacer which, in turn, is coupled on 
the GNPs surface. Both nanostructures obtained, GNP-
JAG-1 (from route I) and GNP-PEG-JAG-1 (from route 
II) were evaluated in terms of size, shape, stability and 
phisico-chemical properties.
UV–Vis spectroscopy measurement results are pre-
sented in Figure  2. The spectra for sample GNP-JAG-1, 
blue line in Figure 1a, presents two SPR bands at 535 and 
652 nm. This bathochromic shift of the initial SPR band 
suggests that JAG-1 has been coupled on the gold nano-
particle surface, but the resulting bio-nanocomposite is 
polydisperse. On the other hand, the GNP-PEG-JAG-1 
UV–Vis spectra registered a single SPR band (Figure 2b—
green line), located at 525  nm, indicating both success-
ful functionalization and a monodiaperse nanoparticle 
population.
Dynamic light scattering (DLS) was used to determine 
the hydrodynamic diameter and polydispersity index of 
both prepared samples. Figure  3a presents a histogram 
for the GNP-JAG-1 sample as measured by DLS. Two 
nanoparticle populations are evident in this case, one 
having a 60 nm diameter (93.8%) and another population 
of JAG-1 functionalized nanoparticles with a diameter of 
228 nm (6.2%). In the case of GNP-PEG-JAG-1, the DLS 
size distribution histogram shown in Figure 3b, a single 
monodisperse population with a hydrodynamic diameter 
of 37 ± 5 nm was registered. The size distribution curves 
for citrate capped GNPs, PEG capped GNPs and GNP-
PEG-JAG-1 are presented in Figure 3c. The PEG capped 
GNPs increased in size, when compared with the citrate 
capped ones, having a 32 nm diameter.
The synthetized nanostructures were also investi-
gated by ATR-FT-IR spectroscopy. Spectra for citrate 
capped GNPs, JAG-1 peptide and GNP-JAG-1 are given 
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in Figure 4a. The IR spectra recorded for the GNP sam-
ple has two characteristic bands at 1,591  cm−1 and at 
1,391  cm−1 corresponding to the antisymmetric and 
symmetric stretching vibrations of COO− from the cit-
rate ions present on the gold nanoparticle surface [31, 
32]. The JAG-1 peptide presented an absorption band 
at 1,599  cm−1 which is attributed mainly to the C–C 
stretching vibrations from tyrosine [33] and phenyla-
lanine [34] residues and a band at 1,413  cm−1 which is 
assigned to the C–N stretching vibrations from the pro-
line [35] residue. The IR spectra of GNP-JAG-1 has a 
1,599  cm−1 absorption band consistent with the one 
found for the JAG-1 peptide at the same wavenumber. As 
for the band registered at 1,413  cm−1 for JAG-1, in the 
case of JAG-1 coupled on the surface of GNPs the band 
has shifted to 1,411 cm−1. The comparison of GNP and 
GNP-JAG-1 IR spectra clearly indicates the presence of 
the JAG-1 peptide on the gold nanoparticle surface.
Figure 1 Illustration of the proposed functionalization routes for binding the JAG‑1 peptide (top chemical structure) to gold nanoparticles.
Figure 2 a UV–Vis spectra of citrate capped GNPs (red line) versus GNP‑JAG‑1 bio‑nanocomposite (blue line) and their corresponding SPR bands. b 
UV–Vis spectra of citrate capped GNPs (red line) versus GNP‑PEG‑JAG‑1 (green line) and their corresponding SPR bands.
Page 5 of 10Matea et al. J Nanobiotechnol  (2015) 13:41 
In the case of GNP-PEG-JAG-1 we first compared the 
spectra of citrate capped GNPs (Figure  4b—red line) 
versus PEG capped GNPs (Figure  4b—dark-green line). 
The initial 1,591 and 1,391 cm−1 absorption bands inten-
sities, coming from the initial citrate layer of the GNPs, 
are shifted, after PEG dithiol addition, to 1,578 and 
1,390  cm−1, respectively. This, and the appearance of 
an absorption band at 1,114 cm−1 which is attributed to 
the backbone C–O–C stretching of PEG [36] confirms 
the successful PEGylation of the gold nanoparticles. The 
JAG-1 coupling onto the GNP-PEG nanostructures is 
confirmed by the presence of the peptides ‘fingerprint’ 
Figure 3 Dynamic light scattering (DLS) size distribution histogram of a GNP‑JAG‑1 sample; b GNP‑PEG‑JAG‑1 sample. c Size distribution curves 
determined by DLS technique for citrate capped GNPs (red), PEG capped GNPs (green) and GNP‑PEG‑JAG‑1 bio‑nanocomposite (blue).
Figure 4 a ATR‑FT‑IR recorded spectra for citrate capped GNPs (red line), JAG‑1 peptide (green line) and GNP‑JAG‑1 (blue line). b ATR‑FT‑IR recorded 
spectra for citrate capped GNPs (red line), PEG capped GNPs (dark-green line) and GNP‑PEG‑JAG‑1 bio‑nanocomposite (blue line).
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absorption bands at 1,599 and 1,415  cm−1 in the GNP-
PEG-JAG-1 sample.
Atomic force microscopy (AFM) measurements were 
conducted on the monodisperse GNP-PEG-JAG-1 sam-
ple, in order to further understand the shape and size 
of the obtained bio-nanostructures. Figure  5a depicts a 
2D representation of GNP-PEG-JAG-1, while Figure  5c 
depicts a 3D representation of the same bio-function-
alized nanoparticle. In both cases, spherical shaped 
nanoparticles with an average diameter of 34 nm can be 
observed. The difference in size between the DLS and 
AFM measurements can be attributed to the fact that 
the DLS technique gives information about the hydro-
dynamic diameter of the gold core surrounded by the 
organic layer and the solvation layers [37]. The cross 
section graph of a representative GNP-PEG-JAG-1 
nanoparticle is presented in Figure 5b. Also a comparison 
of the AFM images obtained for the GNP, GNP-JAG-1 
and GNP-PEG-JAG-1 samples is presented in Additional 
file 1: Figure S1.
High contrast dark-field microscopy was used din 
order to investigate the light scattering characteristics for 
citrate capped GNPs (Figure 6a) and for the GNP-PEG-
JAG-1 bio-nanostructure (Figure 6b) in DI water. The lat-
ter one shows a scattering resonance red shift after the 
functionalization step, an indication of diameter size 
increase.
The hydrodynamic stability of the GNP and GNP-
PEG-JAG-1 samples were evaluated in NaCl solutions 
with various concentrations (NaCl 0  mM; 9.625  mM; 
19.25  mM; 38.5  mM; 77  mM; 154  mM; 308  mM; 
500 mM; 1,000 mM) by means of UV–Vis spectroscopy. 
Figure 5 AFM measurement of GNP‑PEG‑JAG‑1: a 2D image (scale bar 100 nm); b cross section graph of a single GNP‑PEG‑JAG‑1 nanoparticle; c 3D 
rendering of GNP‑PEG‑JAG‑1.
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In Figure 7a The position of the SPR band for the GNP 
sample was affected by the presence of NaCl ions in the 
dispersing medium; at a 0  mM NaCl concentration the 
λmax = 522 nm, this peak decreases in intensity inversely 
proportional to the NaCl concentration. This phenom-
ena can be explained by the fact that the citrate capped 
GNPs tend to agglomerate in presence of NaCl. By con-
trast, the UV–Vis spectra of the GNP-PEG-JAG-1 sample 
(Figure  7b) exposed to various concentrations of NaCl 
solutions (NaCl 0 mM; 9.625 mM; 19.25 mM; 38.5 mM; 
77 mM; 154 mM; 308 mM; 500 mM; 1,000 mM) remains 
unchanged regardless of the NaCl concentrations. The 
GNP-PEG-JAG-1 sample stability was also tested in 
DMEM culture media and monitored by means of UV–
Vis spectroscopy and DLS techniques. Figure 7c depicts 
the UV–Vis spectra of GNP-PEG-JAG-1 in H2O (red line) 
and DMEM cell culture media (blue line), in both cases 
the SPR band was centered at around 525 nm indicating 
no agglomeration of the PEG-JAG-1 functionalized gold 
nanoparticles. This is in agreement with the DLS results, 
depicted in Figure  7d, GNP-PEG-JAG-1 in DMEM cell 
culture media registered a single monodisperse popula-
tion with a hydrodynamic diameter of 36 ± 9 nm.
No significant change in viability/proliferation rate 
was observed for the MC3T3-E1 osteoblast cell line 
after exposure to various concentrations of nanoma-
terial (across group significance p  =  0.591; control 
vs 34.5  μg  mL−1 p  =  0.077, control vs 4.3  μg  mL−1 
p = 0.376). However, a bimodal effect could be observed: 
while higher concentrations of the bio-nanostructure 
decreased the proliferation rate (34.5 μg mL−1 GNP-PEG-
JAG-1 and 17.3  μg  mL−1 GNP-PEG-JAG-1), the lower 
concentration values tend to promote cell proliferation 
(8.6 μg mL−1 GNP-PEG-JAG-1, 4.3 μg mL−1 GNP-PEG-
JAG-1), as shown in Figure 8.
Discussions
The objective of our present study was to develop a 
rational route to functionalize gold nanoparticles with 
the JAG-1 protein active peptide fragment. Two routes 
were proposed and investigated in terms of the synthe-
tized bio-nanostructures.
Gold nanoparticles with different sizes and function-
alities were developed and analyzed in recent years for 
a wide range of biomedical applications [7], one of them 
being the transport and unloading of pharmaceuticals. In 
a study conducted by Wang et  al. GNPs were shown to 
greatly enhance intracellular peptide delivery [38].
The JAG-1 peptide is a Notch agonist with in vitro 
activity corresponding to JAGGED-1 protein residues 
188–204 and is a part of the Delta/Serrate/LAG-2 region 
[2]. The 17 aminoacid JAG-1 peptide (Figure 1—top-side) 
has three cysteine residues in its structure. These thiol 
containing residues were used in order to couple the pep-
tide on the gold nanoparticle surface. Even though the 
formation GNP-peptide conjugates, (via cysteine) has 
been previously described in literature [39, 40], more 
recent studies suggest the phenomena is not fully under-
stood and the Au–sulphur interactions may be partially 
covalent and partially noncovalent [38, 41, 42].
Firstly, we have synthesized citrate capped GNPs 
because of their excellent size distribution very good sta-
bility in aqueous media and their ability to react with a 
broad range of ligands [27]. UV–Vis measurements for 
the synthesized GNPs showed a SPR band located at 
522 nm, DLS measurements confirmed the monodisperse 
Figure 6 High contrast dark‑field microscopy images for a citrate capped GNPs sample and b GNP‑PEG‑JAG‑1 bio‑nanocomposite.
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character and their 16 nm size, while the ATR-FT-IR data 
confirmed the presence of citrate ions on the surface of 
the gold nanoparticles.
In the first route, the JAG-1 peptide was directly cou-
pled on the GNPs via thiol–Au interaction. The synthe-
tized citrate capped GNPs were introduced to JAG-1 
under vigorous agitation and neutral pH. The resulting 
GNP-JAG-1 sample had UV–Vis spectra with two SPR 
bands, one at 535 nm and another one at 652 nm. The sec-
ond SPR band is attributed to the dipole coupling between 
plasmons of neighboring particles forming aggregates 
[43]. The formation of aggregates when JAG-1 was added 
to citrate capped GNPs is also confirmed by the DLS 
measurements who revealed a polydisperse GNP-JAG-1 
sample with two populations centered at 60 and 228 nm. 
The addition of peptides to citrate-capped GNPs can lead 
to highly stable peptide-capped GNPs or, as in this case, 
in the formation of aggregates, depending on the peptide 
structure [43]. Although the GNP-JAG-1 bio-nanostruc-
ture proved polydisperse, ATR-FT-IR investigations were 
carried out in order to find out if indeed the JAG-1 pep-
tide was coupled onto the GNPs. The IR bands located at 
1,599 and 1,411 cm−1 confirmed this.
The second route employed for the JAG-1 function-
alization of GNPs involved the place-exchange reac-
tion between citrate ions present on the GNPs and 
dithiol PEG. The reaction was monitored via UV–Vis, 
Figure 7 a UV–Vis spectra of citrate capped GNPs dispersed in NaCl solutions (concentrations ranging from 0 to 1,000 mM NaCl); b UV–Vis spectra 
of GNP‑PEG‑JAG‑1 dispersed in NaCl solutions (concentrations ranging from 0 to 1,000 mM NaCl); c UV–Vis spectra of GNP‑PEG‑JAG‑1 dispersed in 
water (red line) versus GNP‑PEG‑JAG‑1 dispersed in DMEM (blue line); d DLS size size distribution histogram of GNP‑PEG‑JAG‑1 dispersed in DMEM.
Figure 8 MTT viability/proliferation assay of MC3T3‑E1 osteoblast 
cells exposed to different concentrations of GNP‑PEG‑JAG‑1.
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ATR-FT-IR and DLS. The PEGylated GNPs presented 
themselves as monodisperse, with a hydrodynamic diam-
eter of 32 nm and an IR absorption band at 1,114 cm−1 
attributed to the backbone C–O–C stretching of PEG. 
The second step of this route was to bind cysteine ter-
minated JAG-1 peptide with the PEGylated GNPs. In 
order to achieve this JAG-1 was introduced to GNP-PEG 
in the presence of DMSO as an oxidizing agent so that 
a disulfide bond was formed between the cysteine from 
JAG-1 and the thiol terminated PEG of the GNPs.
The UV–Vis spectra of GNP-PEG-JAG-1 presented a 
SPR band at 525  nm, this bathochromic shift indicates 
the place exchange reaction occurring between the PEG 
dithiol and the citrate ions initially found on the GNPs. 
DLS measurements for citrate capped GNPs, PEGylated 
GNPs and GNP-PEG-JAG-1 samples showed them as 
being monodisperse with hydrodynamic diameters of 16, 
32 and 37 nm respectively. Confirmation of the PEGyla-
tion and JAG-1 functionalization steps also came from 
the ATR-FT-IR spectras, data presented in the results 
section. AFM measurements conducted on the GNP-
PEG-JAG-1 sample showed the synthetized nanostruc-
ture as being spherical in shape.
The results obtained showed that the presence of a 
PEG spacer between the JAG-1 peptide and the gold core 
yields a monodisperse, aqueous stable nanometric struc-
ture. Moreover, biological activity results reveal no signif-
icant toxicity and low GNP-PEG-JAG-1 concentrations 
tend to induce the intended osteoblast—stimulatory 
effect. The lack of cytotoxic significance could be due to 
the limited 1-h incubation used. Further strategies should 
be tried to optimize this effect (exposure time prolonga-
tion, chronic exposure, etc.). Further research studies are 
needed to asses the Notch pathway activation potential of 
this novel bio-nanostructure. This study indicates a new 
strategy in delivering protein active peptide fragments 
with the aid of gold nanoparticles.
Conclusions
We have investigated two functionalization routes to cou-
ple the JAG-1 peptide with gold nanoparticles. The het-
ero-functionalized GNP-PEG-JAG-1 bio-nanostructure 
obtained had a 37 nm diameter and was stable in aqueous 
media. Our results could have a significant impact in the 
assembly routes employed to bind biological active pep-
tides to gold nanoparticles. The activation potential of 
the Notch pathway by this newly synthetized bio-nano-
composite is under investigation by our research group.
Additional files
 Additional file 1: Figure S1. AFM images of citrate capped GNPs (left 
image), JAG‑1 functionalized GNPs (centre image) and PEG‑JAG‑1 func‑
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